| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 18
| Issue : 77 | Page : 4-9 |
|
|
Rehmanniae Radix-Induced apoptosis via inhibition of PI3K/AKT/mTOR signaling pathways in human hepatocellular carcinoma cell lines SMMC-7721
Bonian Liao, Fangli Luo, Shu Zhang, Zhengwan Deng, Lin Cai
Department of Traditional Chinese Medicine, Affiliated Hospital of North Sichuan Medical College, Shunqing District, Nanchong, Sichuan, China
Correspondence Address:
Lin Cai
Department of Traditional Chinese Medicine, Affiliated Hospital of North Sichuan Medical College, No. 1, MaoYuan South Road, Sichuan - 637 000
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/pm.pm_147_21
|
|
|
Background: Hepatocellular carcinoma (HCC) grades second among cancer-related deaths. Rehmanniae Radix (RR) has been exposed to have numerous pharmacological properties. Objectives: To inspect RR leaves extracts pro-apoptotic activities on SMMC-7721 liver cancer cell lines. Materials and Methods: Anti-cancer effect of RR extracts in SMMC-7721 liver cancer cell lines was aged rate of cell apoptosis (AO/EB, 4′,6-diamidino-2-phenylindole [DAPI], and PI staining), ΔΨm (Rh-123 staining), intracellular Reactive oxygen species (ROS) (DCFH-DA staining), quantitative polymerase chain reaction (mRNA expressions of Bax, p53, Bcl-2, caspase-3,-9,-8, IL-6, PI3K/AKT, and mTOR). Results: It has been shown that RR leaf ethanolic extracts suggestively declined cell viability, augmented the rate of cell apoptosis (AO/EB, DAPI, and PI staining), and caused the potential for ΔΨm, and induced over-accumulation of intracellular ROS (DCFH-DA staining) in SMMC-7721 cells after 24 h of exposure. In SMMC-7721 cell lines, we have examined anti-cancer activity to scrutinize the underlying mechanism by assessing the mRNA expressions of Bax, p53, Bcl-2, caspase-3,-9,-8, IL-6, PI3K/AKT, and mTOR. Results displayed the significant inhibition of the apoptosis as stated above related proteins. Conclusion: RR extracts exhibited its potential anti-cancer activity against SMMC-7721 cells by prompting apoptosis-induced cell death and inhibiting PI3K/AKT/mTOR signaling.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
